Levetiracetam Hexal 500 mg, filmomhulde tabletten
Dit geneesmiddel is goedgekeurd voor gebruik bij de hier vermelde indicatie.
Verkrijgbaarheid: Uitsluitend recept
Over dit geneesmiddel
Werkzame stof: |
LEVETIRACETAM
500 mg/stuk
|
ATC: |
N03AX14 - Levetiracetam
|
Hulpstoffen: |
CELLULOSE, MICROKRISTALLIJN (E 460(i))
CROSCARMELLOSE NATRIUM (E 468)
CROSPOVIDON (E 1202)
HYPROLOSE (E 463)
HYPROMELLOSE (E 464)
IJZEROXIDE GEEL (E 172)
MACROGOL 600
MAGNESIUMSTEARAAT (E 470b)
POVIDON K 25 (E 1201)
SILICIUMDIOXIDE (E 551)
TALK (E 553 B)
TITAANDIOXIDE (E 171)
|
Farmaceutische vorm: |
Filmomhulde tablet
|
Toedieningsweg: |
Oraal gebruik
|
Informatie voor de patiënt
1. What [Nationally completed name] is and what it is used for
Levetiracetam is an antiepileptic medicine (a medicine used to treat seizures in epilepsy).
[Nationally completed name] is used:
• on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat a certain form of epilepsy. Epilepsy is a condition where the patients have repeated fits (seizures). Levetiracetam is used for the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain (partial onset seizure with or without secondary generalisation). Levetiracetam has been given to you by your doctor to reduce the number of fits.
• as an add-on to other antiepileptic medicines to treat :
o partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age;
o myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy;
o primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in adults and adolescents from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
Een uitgebreide beschrijving van de werkzaamheid en mogelijke bijwerkingen van dit geneesmiddel vindt u in de patiëntenbijsluiter en samenvatting van de productkenmerken.
Betrouwbare websites van het Netwerk Patiënteninformatie
Wilt u meer weten over ziekte en gezondheid? Kijk dan op Thuisarts.nl.
Registratienummer: |
RVG 108537 |
Procedurenummer: |
NL/H/2152/002 |
Datum verstrekking handelsvergunning: |
21 september 2011 |
Handelsvergunninghouder: |
Hexal AG
Industriestrasse 25
D-83607 HOLZKIRCHEN (DUITSLAND)
|